cardiac surgery-associated acute kidney injury

Advertisement

cGxPJobs Banner

Arch Biopartners Expands LSALT Peptide Phase 2 Kidney Injury Trial to U.S.

TORONTO, Canada, August 11, 2026 Arch Biopartners Inc. announced plans to expand its ongoing Phase 2 clinical trial of...

By cGxPwire Editor
August 13, 2026

Read More

Advertisement

cGxPJobs

Directory